ECG CHANGES IN DOGS SEDATED WITH DEXMEDETOMIDINE AND MIDAZOLAM- DEXMEDETOMIDINE COMBINATION

Similar documents
Clinical applicability of dexmedetomidine for sedation, premedication and analgesia in cats 1 / 2007

SUMMARY OF PRODUCT CHARACTERISTICS

Dexmedetomidine. Dr.G.K.Kumar,M.D.,D.A., Assistant Professor, Madras medical college,chennai. History

DISSOCIATIVE ANESTHESIA

Dexmedetomidine and its Injectable Anesthetic-Pain Management Combinations

SUMMARY OF PRODUCT CHARACTERISTICS

Premedication with alpha-2 agonists procedures for monitoring anaesthetic

Dexmedetomidine: Systemic effects and clinical application in animals

Pain Management in Racing Greyhounds

SUMMARY OF PRODUCT CHARACTERISTICS

Sripati Sethi, J Singh, I Nath, RK Das, S Nayak and Rajesh K Sahu

Summary of Product Characteristics

A New Advancement in Anesthesia. Your clear choice for induction.

N.C. A and T List of Approved Analgesics 1 of 5

Northwest A&F University, College of Veterinary Medicine, Yangling, China 3

T u l a n e U n i v e r s i t y I A C U C Guidelines for Rodent & Rabbit Anesthesia, Analgesia and Tranquilization & Euthanasia Methods

SUMMARY OF PRODUCT CHARACTERISTICS

Sedative and antinociceptive effects of dexmedetomidine and buprenorphine after oral transmucosal or intramuscular administration in cats

Non-invasive, mildly to moderately painful, procedures and examinations which require restraint, sedation and analgesia in dogs and cats.

What dose of methadone should I use?

DOI /yydb medetomidine a review of clinical applications J. Curr Opin Anaesthesiol

Alfaxan. (alfaxalone 10 mg/ml) Intravenous injectable anesthetic for use in cats and dogs. TECHNICAL NOTES DESCRIPTION INDICATIONS

Candidate Name: PRACTICAL Exercise Medications & Injections

Comparative evaluation of halothane anaesthesia in medetomidine butorphanol and midazolam butorphanol premedicated water buffaloes (Bubalus bubalis)

SUMMARY OF PRODUCT CHARACTERISTICS. Narcostart 1 mg/ml solution for injection for cats and dogs (NL, AT, BE, CZ, EL, HU, IS, LU, PL, SK)

Oxygenation in Medetomidine-Sedated Dogs with and without 100% Oxygen Insufflation

Health Products Regulatory Authority

Day 90 Labelling, PL LABELLING AND PACKAGE LEAFLET

CO Oguntoye* & BO Oke

EVALUATION OF EPIDURAL ANAESTHESIA WITH LIGNOCAINE XYLAZINE MIXTURE IN KETAMINE SEDATED CATS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

COMPARATIVE EVALUATION OF ELECTROCARDIOGRAPHIC EFFECTS OF DIFFERENT DOSES OF MEDETOMIDINE AND XYLAZINE IN CALF-CAMELS (CAMELUS DROMEDARIUS)

A Comparison of the Incidence of Apnoea Following Induction of Anaesthesia with Propofol or Alfaxalone in Dogs

1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT

Propofol vs Dexmedetomidine

VETERINARSKI ARHIV 83 (5), , 2013

Reversal of Medetomidine-Ketamine Combination Anesthesia in Rabbits by Atipamezole

Cepesedan 10 mg/ml, Solution for Injection for Horses and Cattle

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

A study to evaluate buprenorphine at 40 lg kg )1 compared to 20 lg kg )1 as a post-operative analgesic in the dog

Perioperative Pain Management in Veterinary Patients

Thesis Submitted in partial fulfilment of the requirement for the degree of Doctor of Philosophy in VETERINARY SURGERY AND RADIOLOGY

Role of "-Adrenoreceptors In The Regulation of Fore-Stomach Motility in the Goat

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ASMIC 2016 DEXMEDETOMIDINE IN THE INTENSIVE CARE UNIT DR KHOO TIEN MENG

Top 5 Short Procedure Sedation Scenarios

Alfaxalone induction dose following administration of medetomidine and butorphanol in the dog

the same safe, reliable sedation and analgesia as DEXDOMITOR. specifically made for cats that weigh 7 lb or less.

Corresponding author: V. Dua, Department of Anaesthesia, BJ Wadia Hospital for Children, Parel, Mumbai, India.

Anaesthesia and Analgesia of fish

! The best anaesthesia is the one you have experience with!

Cardiovascular, respiratory, electrolyte and acid base balance during continuous dexmedetomidine infusion in anesthetized dogs

SUMMARY OF PRODUCT CHARACTERISTICS

DECISION AND SECTION 43 STATEMENT TO THE VETERINARY COUNCIL BY THE COMPLAINTS ASSESSMENT COMMITTEE: CAC Dr A. (Section 39 referral/complaint)

Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit

PREVALENCE OF CANINE BACTERIAL DERMATITIS IN WEST BENGAL

Preanesthesia in dogs Dog Weight. Sedation/analgesia in dogs Dog Weight. Sedation/analgesia and preanesthesia in cats

PREANAESTHETICS -ANTICHOLINERGICS, SEDATIVES, TRANQUILIZERS

Original Article INTRODUCTION. Abstract

Yamaguchi University. Naotami UEOKA. The United Graduate School of Veterinary Science

Summary of Product Characteristics

Study between clonidine and dexmedetomidine in attenuation of pressor response during endotracheal intubation

EVALUATION OF THE USE OF PENTAZOCINE IN COMBINATION WITH DIAZEPAM AND KETAMINE FOR SURGICAL ANAESTHESIA IN RABBITS

The UCD community has made this article openly available. Please share how this access benefits you. Your story matters!

SUMMARY OF PRODUCT CHARACTERISTICS

USE OF MEDETOMIDINE HYDROCHLORIDE AS SEDATIVE IN CATTLE CALVES

Mouse Formulary. The maximum recommended volume of a drug given depends on the route of administration (Formulary for Laboratory Animals, 3 rd ed.

Clinicophysiological, haematobiochemical and haemodynamic effect of propofol and ketamine with dexmedetomidine in urolithic goats

Canine Dosing Chart DEXDOMITOR

Susan Becker DNP, RN, CNS, CCRN, CCNS Marymount University, Arlington, VA

Standing sedation with medetomidine and butorphanol in captive African elephants (Loxodonta africana)

Procedure # IBT IACUC Approval: December 11, 2017

Vol. 24, No. 5 May Animal Care Center of Sonoma County Sonoma, California Marcia L. Aubin, DVM, MS*

A SYSTEMATIC REVIEW ON THE USE OF DEXMEDETOMIDINE AS A SOLE AGENT FOR INTRAVENOUS MODERATE SEDATION

Earn a rebate on pioneering brands you trust.

SUMMARY OF PRODUCT CHARACTERISTICS

take pain out of the pet s experience.

Role of Dexmedetomidine as an Anesthetic Adjuvant in Laparoscopic Surgery

Associate Professor, Department of Anaesthesiology, Government Thoothukudi Medical College, Thoothukudi, Tamil Nadu, India, 2

Field Anesthesia Techniques in Camelids

PDF of Trial CTRI Website URL -

Int.J.Curr.Microbiol.App.Sci (2018) 7(6):

DOSE ROUTE FREQUENCYREFERENCENOTES

Module C Veterinary Anaesthesia Small Animal Anaesthesia and Analgesia (C-VA.1)

Evaluation of dexmedetomine in anesthesia care for elderly patients with obstructive sleep apnea

Rajaclimax Kirubahar, Bose Sundari, Vijay Kanna*, Kanakasabai Murugadoss

Ilona Rodan, DVMDABVP. Questions and Answers from March 5 18, 2012 AAHA Web Conference

EVALUATION OF EFFECTS OF DIFFERENT COMBINATIONS OF SELECTED SEDATIVES ON THE HEMATOLOGICAL PROFILE OF STANDING SEDATED HORSES ABSTRACT

Dexmedetomidine versus ketamine combined with midazolam; a comparison of anxiolytic and sedative premedication in children

COMPARISON OF EFFECTS OF XYLAZINE, DETOMIDINE AND MEDETOMIDINE ON HEART RATE, RESPIRATORY RATE AND BLOOD GLUCOSE LEVEL IN SHEEP

The haemodynamic and pharmacologic interaction of medetomidine and peripheral antagonist MK-467 and their dose-dependency in dogs

Alfaxalone use in selected exotic species part 1

Alfaxan FAQs. Repeatable. Reliable. Relax.

Weekly Schedule of Neuroscience (2017/2018) Week 1

Dexmedetomidine and MK-467, a peripherally acting

Metacam. The Only NSAID Approved for Cats in the US. John G. Pantalo, VMD Professional Services Veterinarian. Think easy. Think cat. Think METACAM.

JMSCR Vol 06 Issue 10 Page October 2018

Copyright is owned by the Author of the thesis. Permission is given for a copy to be downloaded by an individual for the purpose of research and

SUMMARY OF PRODUCT CHARACTERISTICS. Euthasol vet. 400 mg/ml, solution for injection (AT, BE, DK, EE, EL, FI, IE, IS, LT, LU, LV, NO, PL, RO SE, UK)

Transcription:

ECG CHNGES IN DOGS SEDTED WITH DEXMEDETOMIDINE ND MIDZOLM- DEXMEDETOMIDINE COMINTION Raja ijaz hmad 1, marpal 2, H. P. ithal 2, P. Kinjavdekar 3, and. M Pawde 3 1 PhD Scholar, 2 Senior Scientist, 3 Principal Scientist, Division of Surgery Division of Surgery, Indian Veterinary Research Institute, Izatnagar-243122 (UP), India The present study was conducted in clinically healthy dogs to investigate the electrocardiographic changes produced by dexmedetomidine, an alpha-2 agonist and its combination with midazolam. Electrocardiographic changes like sinus arrhythmia, first degree heart block and wandering pace maker were recorded in both groups. P wave duration was variable whereas amplitude decreased in both groups. Dexmedetomidine induced bradycardia caused increased in PR interval in both groups. QRS complex duration and amplitude increased in both groups. T wave complex was also increased but its morphology is not of any significant value in small animals. ddition of midazolam did not cause considerable adverse effects on ECG changes induced by dexmedetomidine in dogs. Key words: DExmedetomidine, dogs, electrocardiography, Midazolam. Introduction Dexmedetomidine, the latest alpha-2 agonist, is the active optical isomer of racemate medetomidine, which is used as a sedative and preanaesthetic in veterinary practice. Studies have revealed that dexmedetomidine may offer sedative and analgesic benefits over medetomidine. In dogs, dexmedetomidine produces dose dependent sedation and analgesia and the intensity of these effects is similar to that produced by twice the dose of medetomidine (Kuusela et al., 2000). Dexmedetomidine; like other alpha-2 agonists, acts on the presynaptic alpha-2 receptors on various neuronal and non-neuronal sites and inhibits noradrenaline release from sympathetic nerve terminals. The alpha-2 adrenergic receptor mediates its effects by activating G- proteins, which modulate cellular activity by signaling a second messenger system, leading to the inhibition of adenylate cyclase which in turn results in decreased formation of 3, 5- cyclic adenosine monophosphate (cmp) (Cotecchia et al., 1990, irnbaumer et al., 1990). ll these events lead to efflux of K+ through an activated channel causing hyperpolarization and suppression of neuronal firing. Ca++ entry into the nerve terminals is also reduced by alpha-2 adrenoreceptor activation, which may be responsible for its inhibitory effects on secretion of neurotransmitters (Hayashi and Maze, 1993, Khan et al., 1999). dministration of alpha-2 agonists is associated with a number of electrocardiographic changes. Sinus bradyarrhythmia, V block, sinus pause are not uncommon (Lemke, 2004). enzodiazepines like midazolam have been used with dexmedetomidine to enhance muscle relaxation and sedation (hmad et al., 2011). The benefits of a combination of a benzodiazepine and an alpha-2 agonist lie not only in induction of profound muscle relaxation and sedation but also in the ability to selectively counteract CNS depression with receptor specific antagonist (Tranquilli et al., 1990). Electrocardiographic profile is an important indicator of functional and physiological status of the heart, however, it has not been studied sufficiently when combination of dexmedetomidine and midazolam was used. The present study was therefore conducted to evaluate the effect of dexmedetomidine and its combination with midazolam on electrocardiographic parameters in dogs. Materials and Methods The study was conducted in the Division of Surgery and Referral Veterinary Polyclinic, Indian Veterinary Research Institute, Izatnagar. nimals Client owned, mixed breed dogs of either sex, with a average weight of 17 kg and average age of 2 years, presented to the Referral Veterinary Polyclinic for minor therapeutic and diagnostic procedures like radiography, clinical examination, abscess drainage, wound dressing etc. were made the subjects for the study. n informed consnt was obtained from the animal owners before Indian Journal of Canine Practice 154 Volume 4 Issue 2, December, 2012

conducting the experiment. The study was conducted on 8 apparently healthy adult dogs, divided randomly into two groups of four animals each. The groups of animals were designated as group and group. 3 In group, dexmedetomidine 20 μg/kg, while in group, dexmedetomidine (20 μg/kg) along with midazolam (0.2 mg/kg) was administered intramuscularly. The animals were restrained properly and spirit swab was used to disinfect the skin over the anterior thigh muscles (biceps femoris) and the drugs were administered using disposable syringes. The animals were restrained on a nonconductive surface to eliminate electrical interference. The animals were kept in right lateral recumbency with fore and hind limbs perpendicular to the long axis of the body. Clip electrodes were attached directly to the animal s skin. The right arm (R) and left arm (L) electrodes were attached proximal to olecranon on the caudal aspect of the respective leg. The right foot (RF) and left foot (LF) electrode clips were attached over the patellar ligament on the anterior aspect of the respective hindlimb. The skin and electrodes were moistened with 70% alcohol before application of ECG electrodes. Electrocardiographic recordings at 1 mv and 50 mm/s paper speed were made at 0, 10, 15, 20, 30, 45, 60, 75, 90, 105 and 120 min intervals using ECG Machine, Cardioart 6108T, (PL Limited, India) on a lead II system. Statistical nalysis Paired t test was used to compare the mean values between the two groups and also at different intervals with their base values in each group (Snedecor and Cochran, 1980). Fig. 1: ECG tracings showing some of the ECG changes recorded in group Results and Discussion Values of various ECG parameters recorded in two groups at different intervals are presented in table 1. Some of the important changes are also depicted in Fig. 1. Normal sinus rhythm was present in all the dogs at the baseline. fter drug administration sinus bradyarrhythmia was observed in all the animals of group. In group, sinus block was observed in one animal. In group, along with sinus arrhythmia, first degree heart block and wandering pacemaker within S node were seen. dministration of alpha-2 agonists is associated with a number of electrocardiographic changes. Sinus bradyarrhythmia, V block, sinus pause are not uncommon (Lemke, 2004). ccentuated sinus arrhythmia with sinus pauses along with occasional first degree -V block have been Indian Journal of Canine Practice 155 Volume 4 Issue 2, December, 2012

reported following dexmedetomidine administration in dogs (Kuusela et al., 2000). Second degree V block with wandering pacemaker and escape beats were detected in some dogs in which medetomidinehydromorphone combination was used (Kuo and Keegan, 2004) whereas sinus arrhythmia with second degree heart block was seen after administration of combination of medetomidine-ketamine (Ko et al., 2000). Table 1: Mean ±SE of various ECG parameters recorded in different groups at different interval Paramete r Gro up 0 10 15 20 30 45 60 75 90 105 120 P-wave duration 0.040 0.038 a 0.045b 0.037 0.044 0.038 ±0001 0.046 0.038 0.040 0.034 0.043 0.043 0.035 0.005 0.041 0.039 ±0001 0.032 0.040 0.036 P-wave amplitud e 0.170 ±0.013 0.130 ±0.016 0.150 a ±0.160 0.098 b 0.160 ±0.027 0.090 ±0.013 0.130* 0.091 0.120* * ±0.011 0.095 ±0.023 0.140 a 0.088 b ±0.023 0.120 * ±0.018 0.082 0.150 a 0.076 *b 0.140 a ±0.023 0.064 ** b ±0.014 0.140 a ±0.022 * b 0.170 *a ±0.033 * b P-R interval 0.093 0.09 a 0.14 **b 0.098 0.14 ** 7 0.09 ** 0.14 ** a 0.14 **b QRS duration 0.054 0.057 0.060 0.053 0.058 0.060 0.059 0.058 0.057 0.060 QRS amplitud e 1.36 ±0.12 1.05 ±0.14 1.46 a 1.05 b ±0.18 1.53 a 0.84 b ±0.07 1.49 ** ±0.14 1.11 ±0.19 1.49 ** ±0.14 1.08 ±0.19 1.52 **a 1.07 b ±0.18 1.43 a ±0.19 0.87 b ±0.21 1.46 *a 0.95 b ±0.16 1.37 ±0.15 1.01 ±0.17 1.80 *a ±0.18 1.19 b ±0.22 1.40 a ±0.11 1.40 b ±0.21 QT interval 0.22 a 0.17 b 0.24 ±0.022 0.24 ** 0.21 a ±0.019 0.24 **b 0.27 **a 0.21 *b ±0.014 a 6 0.25 **b 0.29 **a 0.25 **b ±0.011 0.29 **a b ±0.015 T wave duration 0.056 0.047 0.085 ** 0.087 0.070 0.075 0.070 0.075 0.080 ±0.090 0.085 0.090 a ±0.014 0.100 b 0.090 * ±0.100 0.080 0.080 a 0.100 b ±0.009 0.080 a 0.210 b ±0.060 0.100 ** 0.100 0.090 ** ±0.009 0.100 ±0.009 T wave amplitud e 0.13 ±0.065 0.18 ±0.080 0.35 ±0.062 0.22 0.31 ±0.058 0.20 ±0.098 0.38 * ±0.050 0.17 0.37 * ±0.060 0.21 0.36 ±0.061 0.20 ±0.110 0.33 ±0.060 0.21 0.40 * ±0.040 0.13 * 0 0.48 ** ±0.011 0.19 0.43 ** ±0.041 0.34 ±0.100 0.34 ±0.063 0.27 P wave duration and amplitude positive P wave was recorded in all the animals of both groups throughout the study period. The duration of P wave did not change much in both the groups after the administration of the drugs. No significant (P>0.05) differences were recorded in the value of duration of P wave at different time intervals as compared to the respective base values. However, a significantly (P<0.05) shorter duration of P wave was recorded in group as compared to group at 10 and 15 min. Thereafter, no significant differences were found between the groups. In group, P wave amplitude decreased significantly (P>0.05) at 20 min (P<0.05) and 30 min (P<0.01) and at 60 min (P<0.05). P wave amplitude improved thereafter and did not differ significantly from Indian Journal of Canine Practice 156 Volume 4 Issue 2, December, 2012

75 to 120 min as compared to the base value. In group, P wave amplitude decreased significantly (P<0.05) at 75 min and this decrease (P<0.01) continued from 90 min to the end of the study.t 10 and 120 min, amplitude in group was significantly (P<0.01) higher than that of group. It has been established that the amplitude of P wave recorded in German Shepherd dogs was related to heart rate; smaller the heart rate, smaller was the amplitude of P wave (vdosko et al., 2010). lthough P wave morphology corresponds to heart rate, however the greatest influence is by autonomic system (Moise, 1998). Dexmedetomidine greatly attenuates sympathetic system, which might be responsible for decreased P wave amplitude in both the groups. Since no significant deviation was observed in group it may be assumed that midazolam did not have a significant effect on P wave amplitude. P-R interval In general, an increase in P-R interval was recorded after administration of the drugs in both groups. In animals of group, P-R interval was significantly (P<0.01) increased at 10 and 20 min after the drug administration and thereafter up to end of the study period. In the animals of group, P-R was significantly (P<0.01) increased at 10 min and persisted so thereafter throughout the study period.. Duration of P-R interval reflects conduction of excitation from atria to ventricles, thus its length is closely related to heart rate. Slower heart rate in the animals of the present study might have been responsible for increased P-R interval (Tilley, 1985). QRS complex duration and amplitude (R wave) In general there was an increase in the duration of QRS complex for variable time period in both groups. In group, QRS complex duration increased significantly (P<0.05) at 20 min as compared to the base value. Thereafter the increase in the duration of QRS complex was consistent and significant (P<0.05) throughout the period of the observation. In group animals, QRS duration increased significantly (P<0.05) at 10 min after the drug administration. It remained significantly (P<0.05) above the baseline values up to 60 min. From 75 min onwards duration of QRS complex decreased towards the baseline and did not vary significantly from the base value up to 120 min. In the animals of group, QRS amplitude at 10 min increased non-significantly (P>0.05) from the base value. The amplitude of QRS complex remained increased significantly (P<0.05) at most of the intervals as compared to the base value. In group, QRS amplitude was not significantly (P>0.05) different at any point of time from the base value. QRS complex amplitude at 10 min was significantly (P<0.05) higher in group as compared to that of group. t 45 to 75 min, group amplitude was significantly (P<0.05) higher than that of group. QRS duration was significantly increased from the base value in both groups and. In dogs under ketaminediazepam anaesthesia, QRS duration increased in Cocker Spaniel dogs whereas in German Shepherd it decreased, implying that QRS duration may be affected by the breed of the dogs (vdosko et al., 2010). In the present study the dogs belonged to mixed breeds and therefore, variable changes may be expected. QRS (R wave) amplitude was increased in both the groups with a significant increase in group at 20, 30 and 45 min of study. The results of the present study conform to the findings of vdosko et al. (2010) who reported increased QRS amplitude in acepromazine premedicated dogs under ketamine-diazepam anaesthesia. QT interval n increase in QT interval was observed after administration of the drugs in both groups. In group animals, QT interval increased non-significantly (P>0.05) from the baseline at 10 min. QT interval increased significantly (P<0.01) at 30 min. Thereafter, this increase in QT interval was significant and consistent at all other observation intervals. The increase in QT interval was more consistent in the animals of groups and. QT interval remained increased significantly (P<0.01) from the baseline throughout the period of the study in group. Duration of QT interval was increased from the base values in both groups significantly up to end of the study period. QT interval varies inversely with heart rate, slower the heart rate longer the QT interval (Tilley, 1985). QT interval is independent of fluctuations in heart rate associated with frequency of ventilation but depends on the mean heart rate. It is also Indian Journal of Canine Practice 157 Volume 4 Issue 2, December, 2012

independent of size and weight of the animal (Oguchi and Hamlin, 1993). T wave duration and amplitude In general an increase of variable extent and duration was recorded in T wave duration in the animals of both groups after administration of the drugs. In group, significant (P<0.01) increase in the duration of T wave was observed at 10 min following administration of the drug. The duration of T wave remained increased throughout the period of the study and this increase was significant (P<0.01) at 105 and 120 min of the study. In group, T wave duration increased after administration of the drugs but remained non-significantly (P>0.05) higher than the base value throughout the period of the study. In group, T wave amplitude remained higher than the base value throughout the study period. This increase was significant (P<0.05) at 20 and 30 min and highly significant (P<0.01) at 90 min. In group, a non-significant (P>0.05) increase in T amplitude was observed throughout the study period as compared to the base value. The differences between the groups were not significant. The diagnostic value of T wave changes in dogs is very limited in comparison with humans, as T wave morphology is highly variable in small animals (Martin, 2007). It was concluded that dexmedetomidine and its combination with midazolam produced electrocardiographic changes like sinus arrhythmia, first degree heart block and wandering pace maker were recorded in dogs. Dexmedetomidine alone or in combination with midazolam caused variable changes in P wave duration whereas amplitude was decreased and PR interval increased in both groups. Similarly, QRS complex duration and amplitude increased in both groups. ddition of midazolam did not cause considerable adverse effects on ECG changes induced by dexmedetomidine in dogs. References hmad, R.., marpal, Kinjavdekar, P., ithal, H.P., Pawde,. M., and Kumar, D. (2011). Effects of midazolam or midazolam- fentanyl on sedation and analgesia produced by intramuscular dexmedetomidine in dogs. sian J. nim. Sci. 5: 302-316. vdosko, G., irgele, E. and Mencendorfa, L. 2010. Changes in elektrocardiogramm of Cocker Spaniel and German Shepherd dogs during anaesthesia. Vet. Med. Zoot. 49:8-16. irnbaumer, L., bramowitz, J. and rown,.m.1990. Receptor effector coupling by G proteins. iochem. iophys. cta. 1031: 163-224. Correa-Sales, C., Rabin,.C. and Maze, M. 1992. hypnotic response to dexmedetomidine, an α-2 agonist, is mediated in the locus coeruleus in rats. nesthesiology 76:948-952. Cotecchia, S., Kobilka,. K., Daniel, K. W., Nolan, R. D., Lapetina, E. Y., Caron, M. G., Lefkowitz, R. J. and Regan, J. W.1990. Multiple second messenger pathways of alpha-adrenergic receptor subtypes expressed in eukaryotic cells. J. iol. Chem. 265: 63-69. Hayashi, Y. and Maze, M. 1993. lpha-2 adrenoceptor agonist and anaesthesia. rit. J. naesth. 71: 108-118. Khan, Z. P., Ferguson, C. N. and Jones, R. M. 1999. lpha-2 and imidazoline receptor agonists: their pharmacology and therapeutic role. naesthesia 54:146-165. Ko, J. C. H., Fox, S. M. and Mandsager, R. E. 2000. Sedative and cardiorespiratory effects of medetomidine, medetomidine-butorphanol, and medetomidine-ketamine in dogs. J. m. Vet. Med. ssoc. 216:1578-1583. Kuo, W. C. and Keegan, R. D. 2004. Comparative cardiovascular, analgesic and sedative effects of medetomidine, medetomidinehydromorphone and medetomidinebutorphanol in dogs. m. J. Vet. Res. 65: 931-937. Kuusela, E., Raekallio, M., nttila, M., Flack, I., Mosla, S. and Vainio, O. 2000. Clinical effects and pharmacokinetics of medetomidine and its enantiomers in dogs. J. Vet. Pharmacol. Therap. 23:15-20. Lemke, K.. 2004. Perioperative use of selective alpha-2 agonists and antagonists in small animals. Can. Vet. J. 45:475-480. Martin, M. 2007. Small nimal ECGs, an introductory guide, 2 nd ed. lackwell Publishing. Moise, N. S. 1998. From cell to cage side: autonomic influences on cardiac rhythms in dog. J. Small nim. Pract. Indian Journal of Canine Practice 158 Volume 4 Issue 2, December, 2012

39:460-468. Oguchi, Y. and Hamlin, R. L. 1993. Duration of QT interval in clinically normal dogs. m. J. Vet. Res. 54:2145-2149. Snedecor, G. W. and Cochran, W. G. (Ed). 1980. Statistical Methods. 9 th ed. Iowa state university press. Tilley, L. P. (Ed). 1985. Essentials of Canine and Feline Electrocardiography. 2 nd ed. Lea & Febiger, Philadelphia. Tranquilli, W. J., Gross, M. E., Thurmon, J. C. and enson, G. J.1990. Evaluation of three midazolam-xylazine mixtures: preliminary trials in dogs. Vet. Surg. 19:168-172. @@»»»»««««@@ SUSCRIPTION The Indian Journal of Canine Practice is a biannual Journal. Subscribers will receive June and December Issues during the period of their subscription. The Subscription rates are as under:- India broad For Institutions Rs.1000.00 $100 or 72 (nnual subscription only) Corporate Members Free Free For Canine Practitioners, Scientists, cademicians and Students nnual Subscription Rs.500.00 $25 or 18 Three Year Subscription Rs.900.00 $25 or 18 Life Members Free Free Currency abbreviations used are Rs. (Indian Rupees), $ (US Dollars) and (ritish Pounds) For subscription, please write to The Editor, I.J.C.P., dvancement of Canine Practice, 21/5, Sector 21, Indiranagar, Lucknow 226 016; India. Indian Journal of Canine Practice 159 Volume 4 Issue 2, December, 2012